Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SOLENO THERAPEUTICS INC | 10%+ Owner | Common Stock | 18M | $658M | $36.49 | Mar 29, 2022 | Indirect |
Sierra Oncology, Inc. | 10%+ Owner | Common Stock, $0.001 par value | 1.31M | $72.3M | $55.00 | Jan 31, 2022 | Indirect |
Vera Therapeutics, Inc. | 10%+ Owner | Class A Common Stock | 2.96M | $53.3M | $18.00 | May 18, 2021 | Indirect |
SOLENO THERAPEUTICS INC | 10%+ Owner | Warrant (right to buy) | 7.72M | Mar 29, 2022 | Indirect | ||
Jasper Therapeutics, Inc. | 10%+ Owner | Stock Option (right to buy) | 78K | Mar 21, 2022 | Indirect | ||
eFFECTOR Therapeutics, Inc. | 10%+ Owner | Stock Option (right to buy) | 40K | Oct 6, 2021 | Indirect | ||
SOLENO THERAPEUTICS INC | 10%+ Owner | Stock Option (right to buy) | 31.9K | Jun 1, 2021 | Indirect | ||
Vera Therapeutics, Inc. | 10%+ Owner | Stock Option (right to buy) | 9.93K | May 13, 2021 | Indirect | ||
Sierra Oncology, Inc. | 10%+ Owner | Series B Warrants (right to buy) | 0 | Jan 28, 2022 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JSPR | Jasper Therapeutics, Inc. | Mar 21, 2022 | 1 | $0 | 4 | Mar 23, 2022 | 10%+ Owner |
SRRA | Sierra Oncology, Inc. | Jan 28, 2022 | 3 | $7.84M | 4 | Feb 1, 2022 | 10%+ Owner |
SRRA | Sierra Oncology, Inc. | Nov 5, 2021 | 0 | $0 | 3 | Nov 5, 2021 | 10%+ Owner |
EFTR | eFFECTOR Therapeutics, Inc. | Oct 6, 2021 | 1 | $0 | 4 | Dec 17, 2021 | 10%+ Owner |
JSPR | Jasper Therapeutics, Inc. | Sep 24, 2021 | 0 | $0 | 3 | Oct 1, 2021 | 10%+ Owner |
EFTR | eFFECTOR Therapeutics, Inc. | Aug 25, 2021 | 0 | $0 | 3 | Aug 27, 2021 | 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 13, 2021 | 3 | $8.5M | 4 | May 18, 2021 | 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 13, 2021 | 0 | $0 | 3 | May 13, 2021 | 10%+ Owner |
SLNO | SOLENO THERAPEUTICS INC | Dec 21, 2018 | 7 | $0 | 4 | Mar 31, 2022 | 10%+ Owner |